Yoshihiko Maehara mostly deals with Internal medicine, Surgery, Cancer, Pathology and Cancer research. His Internal medicine study combines topics in areas such as Gastroenterology and Oncology. The Liver transplantation, Transplantation, Living donor liver transplantation and Hepatectomy research he does as part of his general Surgery study is frequently linked to other disciplines of science, such as In patient, therefore creating a link between diverse domains of science.
His Cancer research is multidisciplinary, relying on both Stomach and Cisplatin. His work investigates the relationship between Pathology and topics such as Angiogenesis that intersect with problems in Vascular endothelial growth factor. His work focuses on many connections between Cancer research and other disciplines, such as Carcinogenesis, that overlap with his field of interest in Epigenetics.
His primary scientific interests are in Internal medicine, Surgery, Gastroenterology, Cancer and Pathology. In his study, Breast cancer is inextricably linked to Oncology, which falls within the broad field of Internal medicine. His work on Liver transplantation, Living donor liver transplantation and Retrospective cohort study as part of his general Surgery study is frequently connected to In patient, thereby bridging the divide between different branches of science.
His Gastroenterology study often links to related topics such as Survival rate. His Cancer research is multidisciplinary, incorporating perspectives in Stomach and Cancer research. His Pathology research integrates issues from Metastasis and Adenocarcinoma.
The scientist’s investigation covers issues in Internal medicine, Gastroenterology, Oncology, Surgery and Cancer research. Lung cancer, Colorectal cancer, Chemotherapy, Cancer and Hepatocellular carcinoma are the core of his Internal medicine study. His research integrates issues of Liver transplantation, Survival rate, Regimen, Clinical endpoint and Hazard ratio in his study of Gastroenterology.
His specific area of interest is Oncology, where Yoshihiko Maehara studies Surgical oncology. His work on Retrospective cohort study is typically connected to In patient as part of general Surgery study, connecting several disciplines of science. The Cancer research study combines topics in areas such as Immunohistochemistry, Cancer cell and Carcinogenesis.
Yoshihiko Maehara mostly deals with Internal medicine, Lung cancer, Immunohistochemistry, Oncology and Gastroenterology. Retrospective cohort study, Sarcopenia, Cancer, Multivariate analysis and Survival rate are the subjects of his Internal medicine studies. His Retrospective cohort study research is included under the broader classification of Surgery.
His Immunohistochemistry study contributes to a more complete understanding of Pathology. His work on Non small cell as part of general Oncology study is frequently linked to In patient, therefore connecting diverse disciplines of science. Yoshihiko Maehara interconnects Pathological, Hepatocellular carcinoma, Hazard ratio, Hepatectomy and Prognostic factor in the investigation of issues within Gastroenterology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma
N. Harimoto;K. Shirabe;Y. I. Yamashita;Toru Ikegami.
British Journal of Surgery (2013)
A gp130-Src-YAP Module Links Inflammation to Epithelial Regeneration
Koji Taniguchi;Koji Taniguchi;Koji Taniguchi;Li Wha Wu;Li Wha Wu;Sergei I. Grivennikov;Sergei I. Grivennikov;Petrus R. De Jong.
Neutrophil–lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment
Takashi Motomura;Ken Shirabe;Yohei Mano;Jun Muto.
Journal of Hepatology (2013)
Epithelial to mesenchymal transition in an epidermal growth factor receptor-mutant lung cancer cell line with acquired resistance to erlotinib.
Kenichi Suda;Kenji Tomizawa;Makiko Fujii;Hideki Murakami.
Journal of Thoracic Oncology (2011)
Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis.
Yohei Mano;Ken Shirabe;Yo Ichi Yamashita;Norifumi Harimoto.
Annals of Surgery (2013)
Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers
Masanori Yoshimatsu;Gouji Toyokawa;Shinya Hayami;Motoko Unoki.
International Journal of Cancer (2011)
Colorectal cancer screening with odour material by canine scent detection
Hideto Sonoda;Shunji Kohnoe;Shunji Kohnoe;Tetsuro Yamazato;Yuji Satoh.
Complications and diagnosis of Meckel's diverticulum in 776 patients.
Hiroki Kusumoto;Motofumi Yoshida;Ikuo Takahashi;Hideaki Anai.
American Journal of Surgery (1992)
Deregulation of the Akt pathway in human cancer.
Eriko Tokunaga;Eiji Oki;Akinori Egashira;Noriaki Sadanaga.
Current Cancer Drug Targets (2008)
Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population.
Minoru Nakamura;Nao Nishida;Minae Kawashima;Yoshihiro Aiba.
American Journal of Human Genetics (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: